Join
Live feed
·
PRReleasevia Quantisnow
Coherus Oncology Inc. logo

Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights

ByQuantisnow·Wall Street's wire, on your screen.
CHRS· Coherus Oncology Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CHRS (Coherus Oncology Inc.) and more on Quantisnow.